3 Year Absolute Returns
81.17% ↑
NAV (₹) on 17 Sep 2026
37.57
1 Day NAV Change
1.24%
Risk Level
Very High Risk
Rating
-
LIC MF Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by LIC Mutual Fund Asset Management Limited. Launched on 08 Feb 2019, investors can start with a minimum ... Read more
AUM
₹ 103.11 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 63.69% |
| Hospitals & Medical Services | 29.16% |
| Chemicals - Others | 5.65% |
| Treps/Reverse Repo | 1.58% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.09% | ₹ 10.41 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 9.29% | ₹ 9.58 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 6.45% | ₹ 6.65 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 6.38% | ₹ 6.58 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 6.23% | ₹ 6.42 | Hospitals & Medical Services |
| Navin Fluorine International Ltd. | 5.65% | ₹ 5.83 | Chemicals - Others |
| Aurobindo Pharma Ltd. | 5.17% | ₹ 5.33 | Pharmaceuticals |
| Aster DM Quality Care Ltd. | 4.82% | ₹ 4.97 | Hospitals & Medical Services |
| Zydus Lifesciences Ltd. | 4.79% | ₹ 4.94 | Pharmaceuticals |
| Gland Pharma Ltd. | 3.93% | ₹ 4.05 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 3.78% | ₹ 3.90 | Hospitals & Medical Services |
| Global Health Ltd. | 3.19% | ₹ 3.29 | Hospitals & Medical Services |
| IPCA Laboratories Ltd. | 3.18% | ₹ 3.28 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 3.17% | ₹ 3.27 | Hospitals & Medical Services |
| Cohance Lifesciences Ltd. | 2.92% | ₹ 3.01 | Pharmaceuticals |
| Mankind Pharma Ltd. | 2.89% | ₹ 2.98 | Pharmaceuticals |
| Artemis Medicare Services Ltd. | 2.88% | ₹ 2.97 | Hospitals & Medical Services |
| Glenmark Pharmaceuticals Ltd. | 2.88% | ₹ 2.97 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 2.55% | ₹ 2.63 | Hospitals & Medical Services |
| Biocon Ltd. | 2.54% | ₹ 2.62 | Pharmaceuticals |
| Dr Agarwal's Health Care Ltd. | 2.54% | ₹ 2.62 | Hospitals & Medical Services |
| Onesource Specialty Pharma Ltd. | 2.21% | ₹ 2.28 | Pharmaceuticals |
| Treps | 1.58% | ₹ 1.63 | Others |
| Syngene International Ltd. | 0.97% | ₹ 1 | Pharmaceuticals |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 18.66% | 15.46% | 8.10% | 21.91% |
| Category returns | 4.79% | 3.47% | 2.67% | 20.14% |
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.89 | 112.26% | 290.64% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.89 | 112.26% | 290.64% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.89 | 112.26% | 290.64% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.51 | 109.42% | 274.83% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.51 | 109.42% | 274.83% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.51 | 109.42% | 274.83% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.55 | 18.94% | 154.92% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.55 | 18.94% | 154.92% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.55 | 18.94% | 154.92% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.46 | 17.78% | 146.71% | 0.00% | ₹11,478 | 1.78% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
LIC MF Gold ETF
ETF
Regular
|
₹135.52 | 36.94% | 150.37% | 216.94% | ₹1,500 | 0.45% |
High
|
|
LIC MF Gold ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹40.91 | 36.25% | 148.45% | 210.70% | ₹858 | 0.35% |
High
|
|
LIC MF Gold ETF FOF
Fund of Funds
Regular
|
₹38.67 | 35.86% | 145.65% | 204.70% | ₹858 | 0.61% |
High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹62.34 | 7.37% | 86.73% | 165.57% | ₹1,174 | 1.35% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹61.21 | 7.37% | 86.59% | 164.43% | ₹1,174 | 1.35% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹61.21 | 7.37% | 86.59% | 164.43% | ₹1,174 | 1.35% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹37.59 | 15.47% | 81.23% | 80.79% | ₹103 | 1.42% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹37.57 | 15.46% | 81.17% | 80.74% | ₹103 | 1.42% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹53.69 | 5.94% | 79.50% | 149.58% | ₹1,174 | 2.69% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹53.69 | 5.94% | 79.50% | 149.58% | ₹1,174 | 2.69% |
Very High
|
What is the current NAV of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
What is the fund size (AUM) of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
What are the historical returns of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
What is the risk level of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
What is the minimum investment amount for LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article